Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites

作者：Katerina Christopoulos, Jonathan Colasanti, Mallory O. Johnson, Manami Diaz Tsuzuki, Xavier A. Erguera, Rey Flores, Jared Kerman, Kaylin V. Dance, John A. Sauceda, Torsten B. Neilands, Samantha E. Dilworth, Kimberly A. Koester, José I. Gutierrez, John A. Schneider, Elizabeth Montgomery, Moira McNulty · 发表于：Open Forum Infectious Diseases · 年份：2022 · DOI：10.1093/ofid/ofac293 · 被引用次数：19 · 研究领域：HIV/AIDS Research and Interventions、HIV, Drug Use, Sexual Risk、LGBTQ Health, Identity, and Policy

Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.